INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 430m ago
HOUSE PTR29m ago
SEC 13F29m ago
ROBINHOOD CHAIN29m ago
GD
Corporate insider

Gala Renee D

Director, President & CEOCIK 0001607737

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 2
Max Insider Score11
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
GD
Gala Renee DDirector, President & CEO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL$225K
1,000 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Jazz Pharmaceuticals plcDirector, President & CEO · Oct 7, 2026
11
GD
Gala Renee DDirector, President & CEO
JAZZJazz Pharmaceuticals plc
Open-market sale · 10b5-1 plan
SELL
$473K
2,000 sh
Oct 6, 2026
Oct 7, 2026
traded Oct 6, 2026
+1d
SEC FORM 4

Evidence